NASDAQ · AEMD
Healthcare · Medical - Devices
$5.58
Down-$0.53 (-9.50%)
Updated Oct 15, 2026, 1:04 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · AEMD
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
AEMD closed at $5.58 after 20 trading sessions, up 290.21% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $5.80 | $5.84 | $5.58 | $5.58 | 44.79K |
| Oct 12, 2026 | $6.01 | $6.05 | $5.82 | $5.86 | 45.12K |
| Oct 9, 2026 | $6.12 | $6.18 | $6.025 | $6.05 | 15.18K |
| Oct 8, 2026 | $6.02 | $6.09 | $6.00 | $6.01 | 24.91K |
| Oct 7, 2026 | $6.02 | $6.175 | $6.00 | $6.07 | 28.54K |
| Oct 6, 2026 | $6.35 | $6.51 | $6.09 | $6.09 | 75.75K |
| Oct 5, 2026 | $6.50 | $6.58 | $6.34 | $6.525 | 96.05K |
| Oct 2, 2026 | $6.54 | $6.69 | $6.3849 | $6.45 | 40.93K |
| Oct 1, 2026 | $6.51 | $6.66 | $6.2612 | $6.63 | 64.21K |
| Sep 30, 2026 | $6.40 | $6.6558 | $6.27 | $6.52 | 118.69K |
| Sep 29, 2026 | $6.25 | $6.42 | $6.1154 | $6.38 | 59.36K |
| Sep 28, 2026 | $6.15 | $6.46 | $5.95 | $6.38 | 142.33K |
| Sep 25, 2026 | $6.64 | $6.672 | $6.1601 | $6.28 | 133.61K |
| Sep 24, 2026 | $6.69 | $6.81 | $6.36 | $6.77 | 152.23K |
| Sep 23, 2026 | $6.56 | $6.94 | $6.31 | $6.81 | 301.96K |
| Sep 22, 2026 | $6.20 | $7.2127 | $6.20 | $6.57 | 764.6K |
| Sep 21, 2026 | $6.89 | $6.9263 | $6.03 | $6.32 | 761.85K |
| Sep 18, 2026 | $6.38 | $6.56 | $5.80 | $6.31 | 2.51M |
| Sep 17, 2026 | $8.48 | $9.50 | $6.01 | $6.78 | 92.6M |
| Sep 16, 2026 | $1.46 | $1.50 | $1.41 | $1.43 | 43.65K |
The latest Smart Investors Daily articles mentioning AEMD.
Company
Market Activity
Research & News
AEMD research
Company profile and research snapshot.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2025 | HC Wainwright & Co. | Neutral | — |
| Mar 10, 2025 | HC Wainwright & Co. | Buy | — |
| Feb 19, 2025 | HC Wainwright & Co. | Buy | — |
| Jan 30, 2025 | HC Wainwright & Co. | Buy | — |
| Nov 15, 2024 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Oct 1, 2026
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call October 1, 2026 11:00 AM EDTCompany ParticipantsJames Frakes - CEO, CFO, Chief Accounting Officer,...
Benzinga · Sep 18, 2026
Aethlon Medical Inc. (NASDAQ: AEMD) shares are dropping Friday, pulling back after the stock surged more than 300% the previous day.
Benzinga · Sep 18, 2026
Aethlon Medical (NASDAQ:AEMD) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and
Benzinga · Sep 17, 2026
Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average rising 0.61% to 51,778.04
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AEMD.
